{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:10:40Z","timestamp":1769098240629,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.diabet.2025.101720","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:33:53Z","timestamp":1764866033000},"page":"101720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Elise","family":"Berchoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Szwarc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-8962","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Pissarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Avignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Jugant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moglie","family":"Le Quintrec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9540-8222","authenticated-orcid":false,"given":"Ariane","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2025.101720_bib0001","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0002","unstructured":"Rapport Rein 2021 [Internet]. [cited 2025 Oct 8]. Available from: https:\/\/back.agence-biomedecine.fr\/uploads\/rapport_rein_2021_2023_06_26_0bcd2b9011.pdf."},{"key":"10.1016\/j.diabet.2025.101720_bib0003","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. Glycemic goals and hypoglycemia: standards of care in diabetes-2024. Diabetes Care 2024;47(Suppl 1):S111\u201325.","DOI":"10.2337\/dc24-S006"},{"key":"10.1016\/j.diabet.2025.101720_bib0004","doi-asserted-by":"crossref","first-page":"708\u201115","DOI":"10.2337\/db11-1015","article-title":"glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study","volume":"61","author":"Ricks","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2025.101720_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/dc06-2037","article-title":"Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study","volume":"30","author":"Snit","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0006","doi-asserted-by":"crossref","first-page":"591\u20118","DOI":"10.1053\/j.ajkd.2011.03.031","article-title":"Red blood cell survival in long-term dialysis patients","volume":"58","author":"Vos","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabet.2025.101720_bib0007","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0042-124577","article-title":"influence of erythropoiesis-stimulating agents on HbA1c and fructosamine in patients with haemodialysis","volume":"125","author":"Rasche","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.diabet.2025.101720_bib0008","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1744-9987.2009.00661.x","article-title":"Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c)","volume":"13","author":"Uzu","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.diabet.2025.101720_bib0009","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc10-0917","article-title":"The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease","volume":"33","author":"Ng","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1515\/CCLM.2000.046","article-title":"Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods","volume":"38","author":"Chachou","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.diabet.2025.101720_bib0011","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/ndt\/gft435","article-title":"Insulin resistance in chronic kidney disease: new lessons from experimental models","volume":"29","author":"Koppe","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.diabet.2025.101720_bib0012","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.nut.2008.12.012","article-title":"Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease","volume":"25","author":"Roubicek","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.diabet.2025.101720_bib0013","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ki.2008.25","article-title":"Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis","volume":"73","author":"Peacock","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabet.2025.101720_bib0014","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diabres.2017.06.012","article-title":"Is there a \"burnt-out diabetes\" phenomenon in patients on hemodialysis?","volume":"130","author":"Abe","year":"2017","journal-title":"Diabetes Res Clin Pr"},{"key":"10.1016\/j.diabet.2025.101720_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.jrn.2008.11.012","article-title":"Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus","volume":"19","author":"Kalantar-Zadeh","year":"2009","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.diabet.2025.101720_bib0016","doi-asserted-by":"crossref","first-page":"1503\u20119","DOI":"10.1038\/sj.ki.5001789","article-title":"Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival","volume":"70","author":"Williams","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabet.2025.101720_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000809","article-title":"Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)","volume":"7","author":"Fokkert","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0018","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13300-019-00741-9","article-title":"Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with type 2 diabetes","volume":"11","author":"Kr\u00f6ger","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabet.2025.101720_bib0019","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF Study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0020","doi-asserted-by":"crossref","first-page":"21\u20119","DOI":"10.1159\/000485843","article-title":"Comparison of glycemic markers in chronic hemodialysis using continuous glucose monitoring","volume":"47","author":"Divani","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.diabet.2025.101720_bib0021","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/ndt\/gfp181","article-title":"Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system","volume":"24","author":"Riveline","year":"2009","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.diabet.2025.101720_bib0022","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2337\/dc22-0073","article-title":"Accuracy of a factory-calibrated continuous glucose monitor in individuals with diabetes on hemodialysis","volume":"45","author":"Villard","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0023","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/dc08-1688","article-title":"Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes","volume":"32","author":"Kazempour-Ardebili","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107549","article-title":"Glycemic variability and all-cause mortality in patients with diabetes receiving hemodialysis: a prospective cohort study","volume":"34","author":"Shi","year":"2020","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2025.101720_bib0025","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/1932296819882690","article-title":"Comparison of interstitial fluid glucose levels obtained by continuous glucose monitoring and flash glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"14","author":"Yajima","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabet.2025.101720_bib0026","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0027","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"Kidney disease: improving global outcomes (KDIGO) Diabetes work group. KDIGO 2022 clinical practice guideline for diabetes management in chronic Kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabet.2025.101720_bib0028","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7754\/Clin.Lab.2015.150742","article-title":"Evaluation of the Tosoh G8 Analyzer and comparison with the Trinity Biotech Premier Hb9210 Analyzer for the measurement of HbA\u2081c","volume":"62","author":"Ucar","year":"2016","journal-title":"Clin Lab"},{"key":"10.1016\/j.diabet.2025.101720_bib0029","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","article-title":"Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study","volume":"107","author":"Joubert","year":"2015","journal-title":"Diabetes Res Clin Pr"},{"key":"10.1016\/j.diabet.2025.101720_bib0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5414\/CN108280","article-title":"Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study","volume":"82","author":"K\u00e9p\u00e9n\u00e9kian","year":"2014","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.diabet.2025.101720_bib0031","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/dc21-0269","article-title":"Hemodialysis-related glycemic disarray proven by continuous glucose monitoring: glycemic markers and hypoglycemia","volume":"44","author":"Hayashi","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0032","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc16-1769","article-title":"Toward defining the threshold between low and high glucose variability in diabetes","volume":"40","author":"Monnier","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0033","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","article-title":"Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro type 2 Diabetes Cohort Study","volume":"17","author":"Cardoso","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2025.101720_bib0034","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101720_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1758-5996-6-139","article-title":"The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c","volume":"6","author":"Xu","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabet.2025.101720_bib0036","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/dia.2024.0145","article-title":"Continuous glucose monitoring metrics and hemoglobin a1c relationship in patients with type 2 diabetes treated by hemodialysis","volume":"26","author":"Galindo","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2025.101720_bib0037","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s11892-012-0286-3","article-title":"Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon","volume":"12","author":"Park","year":"2012","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.diabet.2025.101720_bib0038","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1525-139X.2010.00701.x","article-title":"Glycemic control and burnt-out diabetes in ESRD","volume":"23","author":"Kovesdy","year":"2010","journal-title":"Semin Dial"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:05:18Z","timestamp":1769040318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363625001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1262363625001144"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101720","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101720"}}